The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (19 analysts) rates it buy, with a mean price target of $20.
Huntington Bancshares
HBAN · a US exchange · USD · Market cap $33.6B · 24,641 employees
Huntington Bancshares Incorporated operates as the bank holding company for The Huntington National Bank that provides commercial, consumer, and mortgage banking services.
FAIL · Does not pass the screenAt the last full screen
2026-09-09
Screened 2026-09-09 · the tape above runs as of 21:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 16.63 against the desk's fair-value range, base estimate 23.00, over the last year.
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against today's price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Huntington Bancshares holds its Distribution at $16.63. Consolidating, no directional conviction, held for 64 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 64 days |
| Price at the screen | $16.63 |
| Valuation | 12.79 trailing · 8.86 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.94 |
Five Screens, Shown in Full
Does not pass. Business activity screen
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Business activity: Financials sector | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades at roughly a 38% discount to our $23.00 fair value, narrow competitive moat, 47.60% revenue growth.
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. A 38.3% margin of safety to the base estimate.
Third-party analyst targets: 19 covering, consensus Buy. The average target sits +20% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsEveryday Banking That Fails the Ethics Check
Picture a Midwest bank handing out mortgages and small business loans to regular customers. Huntington Bancshares shows revenue growth of 34 percent and trades at 9.6 times forward earnings, yet the numbers sit beside a narrow moat and an 8 percent return on equity that signals limited pricing power.
We pass for one clear reason. The stock fails our ethical screen on business activity grounds, and that alone keeps it off the list regardless of the 23 percent gap between the current price and our fair value estimate.
Low ROE and thin competitive protection already flag structural weakness, while analyst targets around 20 dollars offer little cushion once the ethical bar is missed. Analysis, not advice.
| Forward P/E | 8.9xcheap for a company growing this fast |
| Trailing P/E | 12.8xreasonably valued |
| EPS, trailing | 1.30 |
| EPS, forward | 1.88 |
| Revenue growth | +47.6%growing very fast |
| Profit margin | 26.1%healthy profit margins |
| Return on equity | 9.0%a modest return on shareholder capital |
| Dividend yield | 385.00% |
| Beta | 0.94steadier than the market |
| Short interest, float | 0.03% |
| 52-week range | 14.89 - 19.46 |
| Moat | NARROW |
| Market cap | $33.6B |
| Employees | 24,641 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeHBAN trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it strong buy, with a mean price target of $20.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 8%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it strong buy, with a mean price target of $20.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Huntington Bancshares (HBAN) Stock Looks Cheap On Fair Value While Earnings Look Fair Simply Wall St. · 16 Jul 2026
- Will Huntington’s New In‑House REIT and Utilities Research Platform Reshape HBAN’s Capital Markets Narrative? Simply Wall St. · 16 Jul 2026
- Huntington Bancshares (HBAN) Expands Equity Research Coverage, Is The Stock Getting Pricey? Simply Wall St. · 15 Jul 2026
- Bank Stocks 'An Island of Stability' as Financial Institutions Set to Release Earnings MT Newswires · 13 Jul 2026
- PNC vs. HBAN: Which Bank Stock Offers Stronger Growth Story? Zacks · 10 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-01 | TATE JEFFREY L. | Director | 9,320 | · | |
| 2026-05-01 | INGLIS JOHN C | Director | 10,523 | · | |
| 2026-05-01 | HEPNER VIRGINIA A | Director | 9,320 | · | |
| 2026-05-01 | SIT ROGER J. | Director | 9,320 | · | |
| 2026-05-01 | DIAZ-GRANADOS RAFAEL ANDRES | Director | 10,523 | · | |
| 2026-05-01 | SHEA TERESA H | Director | 9,320 | · | |
| 2026-05-01 | KLINE KATHERINE M. A. | Director | 9,320 | · | |
| 2026-05-01 | PORTEOUS DAVID L | Director | 10,523 | · | |
| 2026-05-01 | PHELAN KENNETH J. | Director | 10,523 | · | |
| 2026-05-01 | NEU RICHARD W | Director | 10,523 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-05-15 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-05-01 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-04-13 | Ro Khanna | Democrat | Purchase | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $15.96 | +5.8% | · | $1,058 | +5.8% |
| 2 months | $16.38 | +3.1% | · | $1,031 | +3.1% |
| 3 months | $15.32 | +10.2% | $0.16 | $1,112 | +11.2% |
| 6 months | $17.57 | -3.9% | $0.31 | $978 | -2.2% |
| 1 year | $15.71 | +7.5% | $0.62 | $1,115 | +11.5% |
| 2 years | $11.61 | +45.5% | $1.24 | $1,562 | +56.2% |
| 3 years | $9.58 | +76.2% | $1.86 | $1,956 | +95.6% |
| 5 years | $11.58 | +45.8% | $3.09 | $1,724 | +72.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever HBAN does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.